Matsuo M - Search Results

1

Urinary Titin N-Fragment as a Biomarker of Muscle Atrophy, Intensive Care Unit-Acquired Weakness, and Possible Application for Post-Intensive Care Syndrome.

Nakanishi N, Tsutsumi R, Hara K, Matsuo M, Sakaue H, Oto J. Nakanishi N, et al. Among authors: matsuo m. J Clin Med. 2021 Feb 6;10(4):614. doi: 10.3390/jcm10040614. J Clin Med. 2021. PMID: 33561946 Free PMC article. Review.

2

Titin fragment in urine: A noninvasive biomarker of muscle degradation.

Matsuo M, Awano H, Maruyama N, Nishio H. Matsuo M, et al. Adv Clin Chem. 2019;90:1-23. doi: 10.1016/bs.acc.2019.01.001. Epub 2019 Mar 5. Adv Clin Chem. 2019. PMID: 31122607 Review.

3

Urinary Titin Is a Novel Biomarker for Muscle Atrophy in Nonsurgical Critically Ill Patients: A Two-Center, Prospective Observational Study.

Nakanishi N, Tsutsumi R, Hara K, Takashima T, Nakataki E, Itagaki T, Matsuo M, Oto J, Sakaue H. Nakanishi N, et al. Among authors: matsuo m. Crit Care Med. 2020 Sep;48(9):1327-1333. doi: 10.1097/CCM.0000000000004486. Crit Care Med. 2020. PMID: 32706557

4

Assessment of catabolic state in infants with the use of urinary titin N-fragment.

Fukushima S, Nakanishi N, Fujioka K, Suga K, Shirakawa T, Osawa K, Hara K, Tsutsumi R, Urushihara M, Nakagawa R, Awano H, Oto J, Sakaue H, Iijima K, Matsuo M. Fukushima S, et al. Among authors: matsuo m. Pediatr Res. 2022 Jun;91(7):1748-1753. doi: 10.1038/s41390-021-01658-5. Epub 2021 Jul 17. Pediatr Res. 2022. PMID: 34274960

5

Diagnostic and clinical significance of the titin fragment in urine of Duchenne muscular dystrophy patients.

Awano H, Matsumoto M, Nagai M, Shirakawa T, Maruyama N, Iijima K, Nabeshima YI, Matsuo M. Awano H, et al. Among authors: matsuo m. Clin Chim Acta. 2018 Jan;476:111-116. doi: 10.1016/j.cca.2017.11.024. Epub 2017 Nov 23. Clin Chim Acta. 2018. PMID: 29175173

6

Receiver operating curve analyses of urinary titin of healthy 3-y-old children may be a noninvasive screening method for Duchenne muscular dystrophy.

Matsuo M, Shirakawa T, Awano H, Nishio H. Matsuo M, et al. Clin Chim Acta. 2018 Nov;486:110-114. doi: 10.1016/j.cca.2018.07.041. Epub 2018 Jul 24. Clin Chim Acta. 2018. PMID: 30053403

7

Can urinary titin be used for predicting Duchenne muscular dystrophy?

Matsuo M, Awano H, Nishio H. Matsuo M, et al. Clin Chim Acta. 2019 Mar;490:162. doi: 10.1016/j.cca.2018.10.045. Epub 2018 Nov 2. Clin Chim Acta. 2019. PMID: 30395868 No abstract available.

8

Urinary titin as a biomarker in Fukuyama congenital muscular dystrophy.

Sato T, Awano H, Ishiguro K, Shichiji M, Murakami T, Shirakawa T, Matsuo M, Nagata S, Ishigaki K. Sato T, et al. Among authors: matsuo m. Neuromuscul Disord. 2021 Mar;31(3):194-197. doi: 10.1016/j.nmd.2021.01.005. Epub 2021 Jan 13. Neuromuscul Disord. 2021. PMID: 33563515

9

A sandwich ELISA kit reveals marked elevation of titin N-terminal fragment levels in the urine of mdx mice.

Shirakawa T, Ikushima A, Maruyama N, Nambu Y, Awano H, Osawa K, Nirasawa K, Negishi Y, Nishio H, Fukushima S, Matsuo M. Shirakawa T, et al. Among authors: matsuo m. Animal Model Exp Med. 2022 Feb;5(1):48-55. doi: 10.1002/ame2.12204. Epub 2022 Feb 3. Animal Model Exp Med. 2022. PMID: 35229992 Free PMC article.

10

Correlation and precision of serum free bilirubin concentrations determined by single and two peroxidase concentration methods in term or late-preterm newborn infants using a FDA-approved analyzer.

Miwa A, Morioka I, Yokota T, Shibata A, Matsuo K, Fujioka K, Koda T, Morikawa S, Nishio H, Yokoyama N, Nakamura H, Matsuo M, Yamada H. Miwa A, et al. Among authors: matsuo m, matsuo k. Clin Lab. 2012;58(5-6):507-14. Clin Lab. 2012. PMID: 22783582 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,077 results

Search Page